FDA approves new treatment for pediatric patients with type 2 diabetes

FDA approves new treatment for pediatric patients with type 2 diabetes

Silver Spring, MD (STL.News) – The U.S. Food and Drug Administration yesterday approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes.  Victoza is the first non-insulin drug approved to treat type 2 diabetes in pediatric patients since metformin was approved for pediatric use in 2000.  Victoza has been approved to treat adult patients with type 2 diabetes since 2010.

“The FDA encourages drugs to be made available to the widest number of patients possible when there is evidence of safety and efficacy,” said Lisa Yanoff, M.D, acting director of the Division of Metabolism and Endocrinology Products in the FDA’s Center for Drug Evaluation and Research. 

Continue reading FDA approves new treatment for pediatric patients with type 2 diabetes at STL.News.